Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q4 2016 13F Holders as of 31 Dec 2016
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 28,495,649
- Total 13F shares
- 3,124,915
- Share change
- +47,035
- Total reported value
- $22,028,000
- Price per share
- $7.05
- Number of holders
- 24
- Value change
- +$338,627
- Number of buys
- 8
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68235C107:
Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
9.2%
|
2,631,680
|
$13,264,000 | — | 30 Sep 2016 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
100,000
|
$504,000 | — | 30 Sep 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.32%
|
91,878
|
$463,000 | — | 30 Sep 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0.24%
|
69,217
|
$349,000 | — | 30 Sep 2016 | |
| Artal Group S.A. |
13F
|
Company |
0.22%
|
64,102
|
$323,000 | — | 30 Sep 2016 | |
| Manatuck Hill Partners, LLC |
13F
|
Company |
0.2%
|
56,800
|
$286,000 | — | 30 Sep 2016 | |
| Destination Wealth Management |
13F
|
Company |
0.1%
|
29,656
|
$149,000 | — | 30 Sep 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
14,961
|
$75,000 | — | 30 Sep 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.02%
|
6,648
|
$34,000 | — | 30 Sep 2016 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.01%
|
4,014
|
$20,000 | — | 30 Sep 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
2,376
|
$11,000 | — | 30 Sep 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.01%
|
1,899
|
$9,000 | — | 30 Sep 2016 | |
| Carroll Financial Associates, Inc. |
13F
|
Company |
0%
|
850
|
$4,000 | — | 30 Sep 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
732
|
$4,000 | — | 30 Sep 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
715
|
$4,000 | — | 30 Sep 2016 | |
| Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management) |
13F
|
Company |
0%
|
550
|
$3,000 | — | 30 Sep 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
478
|
$2,000 | — | 30 Sep 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
335
|
$2,000 | — | 30 Sep 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
289
|
$1,000 | — | 30 Sep 2016 | |
| Creative Planning |
13F
|
Company |
0%
|
265
|
$1,000 | — | 30 Sep 2016 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
0%
|
210
|
$1,000 | — | 30 Sep 2016 |
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q4 2016
As of 31 Dec 2016,
Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,124,915 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, BRIDGEWAY CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, Manatuck Hill Partners, LLC, BlackRock Institutional Trust Company, N.A., Artal Group S.A., Destination Wealth Management, GEODE CAPITAL MANAGEMENT, LLC, Family Management Corp, and BlackRock Fund Advisors.
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
20
Q4 2016 holders
24
Holder diff
4
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 Value $ | Q4 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.